Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05595460
Title	Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	RayzeBio, Inc.
Indications	lung small cell carcinoma
Therapies	Atezolizumab + Carboplatin + Etoposide + RYZ101
Age Groups:	senior \| adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Research Facility	RECRUITING	Los Angeles	California	90024	United States	Details
Research Facility	RECRUITING	San Francisco	California	94158	United States	Details
Research Facility	RECRUITING	Jacksonville	Florida	32224	United States	Details
Research Facility	RECRUITING	Miami	Florida	33136	United States	Details
Research Facility	RECRUITING	Orlando	Florida	32806	United States	Details
Research Facility	RECRUITING	Tamarac	Florida	33612	United States	Details
Research Facility	RECRUITING	Iowa City	Iowa	52242	United States	Details
Reserach Facility	RECRUITING	Lexington	Kentucky	40536	United States	Details
Research Facility	RECRUITING	Grand Rapids	Michigan	49503	United States	Details
Research Facility	RECRUITING	Troy	Michigan	48098	United States	Details
Research Facility	RECRUITING	Rochester	Minnesota	55905	United States	Details
Research Facility	RECRUITING	Saint Louis	Missouri	63130	United States	Details
Research Facility	RECRUITING	Omaha	Nebraska	68130	United States	Details
Research Facility	RECRUITING	Houston	Texas	77090	United States	Details
Research Facility	RECRUITING	Salt Lake City	Utah	84112	United States	Details
Research Facility	RECRUITING	San Juan		00935	Puerto Rico	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field